Clinical application of bisphosphonates in implant dentistry: Histomorphometric evaluation

International Journal of Periodontics and Restorative Dentistry

Volumn 29, Issue 1, 2009, Pages 31-39

  Zuffetti, Francesco ^a   Bianchi, Francesca ^a   Volpi, Raffaele ^b,c   Trisi, Paolo ^a   Del Fabbro, Massimo ^a   Capelli, Matteo ^a   Galii, Fabio ^a   Caosoni, Franco ^a   Testori, Tiziano ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Italian Society for the Study of Bisphosphonates in Odontostomatology   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BONE DENSITY CONSERVATION AGENT; CLODRONIC ACID;

ARTICLE; BONE REGENERATION; CASE REPORT; DRUG EFFECT; EVALUATION; HUMAN; MALE; MIDDLE AGED; PILOT STUDY; TOOTH IMPLANTATION;

BONE DENSITY CONSERVATION AGENTS; CLODRONIC ACID; DENTAL IMPLANTATION, ENDOSSEOUS; HUMANS; MALE; MIDDLE AGED; OSSEOINTEGRATION; PILOT PROJECTS;

EID: 70350148313     PISSN: 01987569     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA 2000;284:3043-3045.
2. Adeli R, Lekholm U, Rockier B, Brånemark P-l. A 15-year study of osseointegrated implants in the treatment of the edentulous jaws. Int J Oral Surg 1981;10:387-416. (Pubitemid 12014507)
3. Friberg B, JemtT, Lekholm U. Early failures in 4,641 consecutively placed Branemark dental implants: A study from stage 1 surgery to the connection of completed prostheses. Int J Oral Maxillofac Implants 1991;6:142-146.
4. Jaffin RA, Berman CL. The excessive loss of Branemark fixtures in type IV bone: A 5-year analysis. J Periodontol 1991;62:2-4.
5. Goodman SB, Trindade M, Ma T, Geno-vese M, Smith RL. Pharmacologic modulation of periprosthetic osteolysis. Clin Orthop Relat Res 2005;430:39-45.
6. Shea JE, Miller SC. Skeletal function and structure: Implications for tissue-targeted therapeutics. Adv Drug Deliver Rev 2005; 57:945-957.
7. Bukowski JF, Dascher CC, Das H. Alternative bisphosphonate targets and mechanisms of action. Biochem Biophys Res Commun 2005;328:746-750.
8. Naemsch LN, Du X, Sims SM, Dixon SJ. P2 nucleotide receptors in osteoclasts. Drug Develop Res 2001 ;53:130-139.
9. Väänänen K. Mechanism of osteoclast mediated bone resorption: Rationale for the design of new therapeutics. Adv Drug Deliv Rev 2005;57:959-971.
10. Meraw SJ, Reeve CM, Wollan PC. Use of alendronate in peri-implant defect regeneration. J Periodontol 1999;70:151-158.
11. Meraw SJ, Reeve CM. Qualitative analysis of peripheral peri-implant bone and influence of alendronate sodium on early bone regeneration. J Periodontol 1999;70: 1228-1233.
12. Skoglund B, Holmertz J, Aspenberg P. Systemic and local ibandronate enhance screw fixation. J Orthop Res 2004;22: 1108-1113.
13. Tengvall P, Skoglund B, Askendal A, Aspenberg P. Surface immobilized bis-phosphonate improves stainless-steel screw fixation in rats. Biomaterials2004;25: 2133-2138.
14. Yoshinari M, Oda Y, Inoue T, Matsuzaka K, Shimono M. Bone response to calcium phosphate-coated and bisphosphonate-immobilized titanium implants. Bio-materials 2002;23:2879-2885. (Pubitemid 34497078)
15. Narai S, Nagahata S. Effects of alendronate on the removal torque of implants in rats with induced osteoporosis. Int J Oral Maxillofac Implants 2003;18:218-223.
16. Kurth AH, Eberhardt C, Muller S, Steinacker M, Schwarz M, Bauss F. The bis-phosphonate ibandronate improves implant integration in osteopenic ovariec-tomized rats. Bone 2005;37:204-210.
17. Kajiwara H, Yamaza T, Yoshinari M, et al. The bisphosphonate pamidronate on the surface of titanium stimulates bone formation around tibial implants in rats. Biomaterials 2005;26:581-587.
18. Shibutani T, Inuduka A, Horiki I, Luan Q, Iwayama Y. Bisphosphonate inhibits alveolar bone resorption in experimentally-induced peri-implantitis in dogs. Clin Oral Implants Res 2001;12:109-114.
19. Yaffe A, Fine N, Alt I, Binderman I. The effect of bisphosphonate on alveolar bone resorption following mucoperiosteal flap surgery in the mandible of rats. J Periodontol 1995;66:999-1003.
20. Frost HM. The biology of fracture healing. An overview for clinicians. Part I. Clin Orthop Relat Res 1989;248:283-293.
21. Frost HM. The biology of fracture healing. An overview for clinicians. Part II. Clin Orthop Relat Res 1989;248:294-309.
22. Frost HM. The regional acceleratory phenomenon: A review. Henry Ford Hosp Med J 1983;31:3-9.
23. Shih MS, Norrdin RW. Regional acceleration of remodeling during healing of bone defects in beagles of various ages. Bone 1985;6:377-379.
24. Testori T, Volpi R, Del Fabbro M, et al. Studio prospettico multicentrico sull'uti-lizzo topico del disodio clodronato in chirurgia implantare. Implantologia Orale 2005;4:79.
25. Viornery C, Guenther HL, Aronsson BO, Pechy P, Descouts P, Grätzel M. Osteoblast culture on polished titanium disks modified with phosphonic acid. J Biomed Mater Res 2002;62:149-155.
26. Peter B, Zambelli PY, Guicheux J, Pioletti DP. The effect of bisphosphonates and titanium particles on osteoblasts. An in vitro study. J Bone Joint Surg Br 2005;87: 1157-1163.
27. Peter B, Pioletti DP, Terrier A, Rakoto-manana LR. Implant used as drug delivery system: Influence of partial biocoating on the bone remodelling. Eur Cell Mater 2001;2:73-74.
28. Tanzer M, Karabasz D, Krygier JJ, Cohen R, Bobyn JD. The Otto Aufranc Award: Bone augmentation around and within porous implants by local bisphosphonate elution. Clin Orthop Relat Res 2005;441: 30-39.
29. Dixon SJ, Sims SM. P2 purinergic receptors on osteoblasts and osteoclasts: potential targets for drug development. Drug Develop Res 2000;49:187-200.
30. Papapoulos SE. Catabolic and anabolic signals in bone: Therapeutic implications. Curr Opin Clin Nutr Metab Care 2001 ;4: 191-196.
31. Jeffcoat MK. Safety of oral bisphosphonates: Controlled studies on alveolar bone. Int J Oral Maxillofac Implants 2006;21: 349-353.
32. Woo SB, Hellstein JW, Kalmar JR. Narrative review: Bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 2006; 144: 753-761.
33. Ruggiero S, Gralòw J, Marx RE, et al. Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer. J Oncol Pract 2006;2:7-14.